{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:55:00Z","timestamp":1791248100569,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Kaposiform hemangioendothelioma (KHE) is a rare, locally aggressive vascular tumour of childhood. Due to its infiltrative growth and possible development of Kasabach-Merritt phenomenon (KMP) if untreated, early intervention is mandatory. Sirolimus, an mTOR (mammalian target of rapamycin) inhibitor, that has been used extensively in children following solid organ transplantation. Due to its pleiotropic effects, including the downregulation of angiogenic processes, immunomodulation, and reduction of platelet consumption, it has also shown promise in the management of vascular anomalies (VAs) in children.<\/jats:p>\n                  <jats:p>We present our experience with a 7-month-old male patient with KHE of the lower limb and significant motor function impairment who was successfully treated with sirolimus.<\/jats:p>\n                  <jats:p>This case provides evidence of the growing significance of the high efficacy of sirolimus in the treatment of vascular tumours. It also highlights the need for the development of standardized treatment guidelines for VAs in the paediatric population.<\/jats:p>","DOI":"10.1186\/s12887-026-07297-1","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T13:03:59Z","timestamp":1783515839000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sirolimus to the rescue: rapid therapeutic response in kaposiform hemangioendothelioma - case report and literature overview"],"prefix":"10.1186","volume":"26","author":[{"given":"Aleksandra","family":"Filipiuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Hutnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"\u0141aguna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"issue":"2","key":"7297_CR1","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1097\/JOVA.0000000000000113","volume":"6","author":"DC Goldenberg","year":"2025","unstructured":"Goldenberg DC, Vikkula, Miikka, the ISSVA Vascular Anomalies Classification Group, et al. Updated Classification of Vascular Anomalies: A living document from the International Society for the Study of Vascular Anomalies Classification Group. J Vascular Anomalies. 2025;6(2):e113. https:\/\/doi.org\/10.1097\/JOVA.0000000000000113.","journal-title":"J Vascular Anomalies"},{"issue":"1","key":"7297_CR2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jpeds.2012.06.044","volume":"162","author":"SE Croteau","year":"2013","unstructured":"Croteau SE, Liang MG, Kozakewich HP, et al. Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals. J Pediatr. 2013;162(1):142\u20137. https:\/\/doi.org\/10.1016\/j.jpeds.2012.06.044.","journal-title":"J Pediatr"},{"issue":"11","key":"7297_CR3","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/1346-8138.15076","volume":"46","author":"Z Wang","year":"2019","unstructured":"Wang Z, Yao W, Sun H, et al. Sirolimus therapy for kaposiform hemangioendothelioma with long-term follow-up. J Dermatol. 2019;46(11):956\u201361. https:\/\/doi.org\/10.1111\/1346-8138.15076.","journal-title":"J Dermatol"},{"issue":"4","key":"7297_CR4","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s12519-018-0171-5","volume":"14","author":"I Schmid","year":"2018","unstructured":"Schmid I, Klenk AK, Sparber-Sauer M, Koscielniak E, Maxwell R, H\u00e4berle B. Kaposiform hemangioendothelioma in children: a benign vascular tumor with multiple treatment options. World J Pediatr. 2018;14(4):322\u20139. https:\/\/doi.org\/10.1007\/s12519-018-0171-5.","journal-title":"World J Pediatr"},{"issue":"4","key":"7297_CR5","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.pathol.2017.03.001","volume":"49","author":"J Putra","year":"2017","unstructured":"Putra J, Gupta A. Kaposiform haemangioendothelioma: a review with emphasis on histological differential diagnosis. Pathology. 2017;49(4):356\u201362. https:\/\/doi.org\/10.1016\/j.pathol.2017.03.001.","journal-title":"Pathology"},{"issue":"7","key":"7297_CR6","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/pbc.22766","volume":"55","author":"J Blatt","year":"2010","unstructured":"Blatt J, Stavas J, Moats-Staats, et al. Treatment of childhood kaposiform hemangioendothelioma with sirolimus. Pediatr Blood Cancer. 2010;55(7):1396\u20138.","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"7297_CR7","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1002\/ijc.35344","volume":"156","author":"J Zhou","year":"2025","unstructured":"Zhou J, Qiu T, Zhang Z, et al. Consensus statement for the diagnosis, treatment, and prognosis of kaposiform hemangioendothelioma. Int J Cancer. 2025;156(10):1986\u201394. https:\/\/doi.org\/10.1002\/ijc.35344.","journal-title":"Int J Cancer"},{"issue":"4","key":"7297_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/00000478-199304000-00001","volume":"17","author":"LR Zukerberg","year":"1993","unstructured":"Zukerberg LR, Nickoloff BJ, Weiss SW. Kaposiform hemangioendothelioma of infancy and childhood. An aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol. 1993;17(4):321\u20138. https:\/\/doi.org\/10.1097\/00000478-199304000-00001.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"7297_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/DAD.0000000000000983","volume":"40","author":"EF Johnson","year":"2018","unstructured":"Johnson EF, Davis DM, Tollefson MM, Fritchie K, Gibson LE. Vascular Tumors in Infants: Case Report and Review of Clinical, Histopathologic, and Immunohistochemical Characteristics of Infantile Hemangioma, Pyogenic Granuloma, Noninvoluting Congenital Hemangioma, Tufted Angioma, and Kaposiform Hemangioendothelioma. Am J Dermatopathol. 2018;40(4):231\u20139. https:\/\/doi.org\/10.1097\/DAD.0000000000000983.","journal-title":"Am J Dermatopathol"},{"issue":"1","key":"7297_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jpeds.2013.03.080","volume":"163","author":"BA Drolet","year":"2013","unstructured":"Drolet BA, Trenor CC 3rd, Brand\u00e3o LR, et al. Consensus-derived practice standards plan for complicated Kaposiform hemangioendothelioma. J Pediatr. 2013;163(1):285\u201391. https:\/\/doi.org\/10.1016\/j.jpeds.2013.03.080.","journal-title":"J Pediatr"},{"issue":"2","key":"7297_CR11","doi-asserted-by":"publisher","first-page":"e20153257","DOI":"10.1542\/peds.2015-3257","volume":"137","author":"DM Adams","year":"2016","unstructured":"Adams DM, Trenor CC 3rd, Hammill AM, et al. Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies. Pediatrics. 2016;137(2):e20153257. https:\/\/doi.org\/10.1542\/peds.2015-3257.","journal-title":"Pediatrics"},{"issue":"3","key":"7297_CR12","doi-asserted-by":"publisher","first-page":"e30779","DOI":"10.1002\/pbc.30779","volume":"71","author":"AJ Borst","year":"2024","unstructured":"Borst AJ, Eng W, Griffin M, et al. Treatment practices and response in kaposiform hemangioendothelioma: A multicenter cohort study. Pediatr Blood Cancer. 2024;71(3):e30779. https:\/\/doi.org\/10.1002\/pbc.30779.","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"7297_CR13","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1111\/bcp.15202","volume":"88","author":"VEM Harbers","year":"2022","unstructured":"Harbers VEM, van der Salm N, Pegge SAH, et al. Effective low-dose sirolimus regimen for kaposiform haemangioendothelioma with Kasabach-Merritt phenomenon in young infants. Br J Clin Pharmacol. 2022;88(6):2769\u201381. https:\/\/doi.org\/10.1111\/bcp.15202.","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"7297_CR14","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.jpedsurg.2022.11.009","volume":"58","author":"SC Mehl","year":"2023","unstructured":"Mehl SC, Whitlock RS, Ortega RM, et al. No Association of Sirolimus with Wound Complications in Children With Vascular Anomalies. J Pediatr Surg. 2023;58(8):1555\u20139. https:\/\/doi.org\/10.1016\/j.jpedsurg.2022.11.009.","journal-title":"J Pediatr Surg"},{"issue":"8","key":"7297_CR15","doi-asserted-by":"publisher","first-page":"e28936","DOI":"10.1002\/pbc.28936","volume":"68","author":"J R\u00f6ssler","year":"2021","unstructured":"R\u00f6ssler J, Baselga E, Davila V, et al. Severe adverse events during sirolimus off-label therapy for vascular anomalies. Pediatr Blood Cancer. 2021;68(8):e28936. https:\/\/doi.org\/10.1002\/pbc.28936.","journal-title":"Pediatr Blood Cancer"},{"key":"7297_CR16","doi-asserted-by":"publisher","unstructured":"Qiu T, Li Y, Gong X et al. Oral antibiotic prophylaxis for infection in patients with vascular anomalies receiving sirolimus treatment: a multicenter retrospective study. Orphanet J Rare Dis. 2023;18(1):121. Published 2023 May 24. https:\/\/doi.org\/10.1186\/s13023-023-02740-3.","DOI":"10.1186\/s13023-023-02740-3"},{"key":"7297_CR17","doi-asserted-by":"publisher","unstructured":"Neirotti A, Barat V, Coppo P et al. Therapy with sirolimus in vascular anomalies: the experience of two Italian centers on 14 pediatric patients. Front Pediatr. 2024;12:1434493. Published 2024 Jul 17. https:\/\/doi.org\/10.3389\/fped.2024.1434493.","DOI":"10.3389\/fped.2024.1434493"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-026-07297-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-07297-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-07297-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:21:53Z","timestamp":1791246113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-026-07297-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7297"],"URL":"https:\/\/doi.org\/10.1186\/s12887-026-07297-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7388703\/v1","asserted-by":"object"}]},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"16 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication of clinical details and clinical images was obtained from the parents of the patient.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"954"}}